PURPOSE OF REVIEW: Anomalous aortic origins of the coronary arteries (AAOCA) are a primary cause of sudden cardiac death in athletes. This review will detail the epidemiology, pathophysiology, and risk stratification of AAOCA, while also highlighting return-to-play considerations for athletes. RECENT FINDINGS: Sport pre-participation cardiovascular screening methods lack sensitivity and specificity in the identification of AAOCA. For the symptomatic athlete, clinicians must maintain a heightened clinical suspicion for AAOCA in order to proceed with appropriate cardiac imaging and functional assessments. Anomalous origin of the left coronary artery with an interarterial course is considered high-risk and requires sport restriction until surgical correction. In contrast, risks associated with anomalous origin of the right coronary artery are controversial, thus management and sports eligibility decisions may incorporate principles of shared-decision making. SUMMARY: Management options for athletes with AAOCA are complex, requiring a comprehensive clinical evaluation. While advances in multimodality cardiovascular imaging and physiologic functional assessments have improved AAOCA risk stratification, best practice treatment strategies for some AAOCA subtypes remain uncertain. As such, clinical management and sport eligibility decisions require an individualized approach. Future prospective data will guide optimization of treatment strategies for athletes with AAOCA.
PURPOSE OF REVIEW: Anomalous aortic origins of the coronary arteries (AAOCA) are a primary cause of sudden cardiac death in athletes. This review will detail the epidemiology, pathophysiology, and risk stratification of AAOCA, while also highlighting return-to-play considerations for athletes. RECENT FINDINGS: Sport pre-participation cardiovascular screening methods lack sensitivity and specificity in the identification of AAOCA. For the symptomatic athlete, clinicians must maintain a heightened clinical suspicion for AAOCA in order to proceed with appropriate cardiac imaging and functional assessments. Anomalous origin of the left coronary artery with an interarterial course is considered high-risk and requires sport restriction until surgical correction. In contrast, risks associated with anomalous origin of the right coronary artery are controversial, thus management and sports eligibility decisions may incorporate principles of shared-decision making. SUMMARY: Management options for athletes with AAOCA are complex, requiring a comprehensive clinical evaluation. While advances in multimodality cardiovascular imaging and physiologic functional assessments have improved AAOCA risk stratification, best practice treatment strategies for some AAOCA subtypes remain uncertain. As such, clinical management and sport eligibility decisions require an individualized approach. Future prospective data will guide optimization of treatment strategies for athletes with AAOCA.
Entities:
Keywords:
Athlete; anomalous coronary artery; exercise; sudden cardiac death
Authors: Karen K Stout; Curt J Daniels; Jamil A Aboulhosn; Biykem Bozkurt; Craig S Broberg; Jack M Colman; Stephen R Crumb; Joseph A Dearani; Stephanie Fuller; Michelle Gurvitz; Paul Khairy; Michael J Landzberg; Arwa Saidi; Anne Marie Valente; George F Van Hare Journal: Circulation Date: 2019-04-02 Impact factor: 29.690
Authors: Robert E Eckart; Stephanie L Scoville; Charles L Campbell; Eric A Shry; Karl C Stajduhar; Robert N Potter; Lisa A Pearse; Renu Virmani Journal: Ann Intern Med Date: 2004-12-07 Impact factor: 25.391
Authors: Gherardo Finocchiaro; Elijah R Behr; Gaia Tanzarella; Michael Papadakis; Aneil Malhotra; Harshil Dhutia; Chris Miles; Igor Diemberger; Sanjay Sharma; Mary N Sheppard Journal: JACC Clin Electrophysiol Date: 2019-01-30
Authors: Kimberly G Harmon; Jonathan A Drezner; Joseph J Maleszewski; Martha Lopez-Anderson; David Owens; Jordan M Prutkin; Irfan M Asif; David Klossner; Michael J Ackerman Journal: Circ Arrhythm Electrophysiol Date: 2014-03-01
Authors: Barry J Maron; Joseph J Doerer; Tammy S Haas; David M Tierney; Frederick O Mueller Journal: Circulation Date: 2009-02-16 Impact factor: 29.690
Authors: Paolo Angelini; Carlo Uribe; Jorge Monge; Jonathan M Tobis; MacArthur A Elayda; James T Willerson Journal: Catheter Cardiovasc Interv Date: 2015-07-14 Impact factor: 2.692
Authors: Tobias A Fuchs; Julia Stehli; Sacha Bull; Svetlana Dougoud; Olivier F Clerc; Bernhard A Herzog; Ronny R Buechel; Oliver Gaemperli; Philipp A Kaufmann Journal: Eur Heart J Date: 2014-02-19 Impact factor: 29.983